Clinical trials require time and expertise; so they inevitably require some level of support.
Commercial clinical trials of novel drugs cost millions of dollars, but some clinical trials can be inexpensive.
Remunerating or otherwise acknowledging consumers who undertake consumer involvement activities is considered international good practice and should be considered in your budget preparations. Unlike the rest of your team, it is not part of a health consumer’s regular employment to work on your clinical trial. Many consumers are happy to provide their expertise for free, but you should not assume this. If you do not have access to funds to pay them for their time, particularly before funding is sourced, be clear about this. Many consumers will still choose to be involved during early stages if consumer costs are included in grant applications.
There will also be costs associated with communicating with participants you recruit to the trial. CT:IQ has a toolkit to assist with developing participant communication Plans.